Shares of Teleflex TFX rose 0.1% in pre-market trading after the company reported Q3 results.
Quarterly Results
Earnings per share decreased 6.73% year over year to $2.77, which beat the estimate of $2.24.
Revenue of $628,301,000 decreased by 3.09% from the same period last year, which beat the estimate of $619,400,000.
Looking Ahead
Earnings guidance hasn't been issued by the company for now.
Teleflex hasn't issued any revenue guidance for the time being.
Details Of The Call
Date: Oct 29, 2020
Time: 08:00 AM
ET Webcast URL: https://edge.media-server.com/mmc/p/c5jqihrc
Recent Stock Performance
52-week high: $409.27
52-week low: $221.27
Price action over last quarter: down 10.20%
Company Profile
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (23% of sales), interventional (17%), surgical (14%), anesthesia (13%), interventional urology (11%), original-equipment manufacturing (10%), and all other (12%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.